Marimed (MRMD) Operating Expenses (2011 - 2026)

Marimed (MRMD) has 16 years of Operating Expenses data on file, last reported at $15.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $15.2 million, down 5.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.8 million (down 2.73% YoY), and the FY2025 annual result was $60.7 million, up 1.16% from the prior year.
• Operating Expenses improved to $15.2 million in Q1 2026 per MRMD's latest filing, from $15.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $16.0 million in Q1 2025 and troughed at $9.9 million in Q1 2022.
• A 5-year average of $13.6 million and a median of $14.5 million in 2024 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 61.47% in 2022 and fell as far as 10.95% in 2022.
• A 5-year view of Operating Expenses shows it stood at $12.7 million in 2022, then gained by 17.16% to $14.9 million in 2023, then slipped by 5.25% to $14.1 million in 2024, then grew by 6.39% to $15.0 million in 2025, then gained by 0.83% to $15.2 million in 2026.
• Business Quant data shows MRMD's Operating Expenses at $15.2 million in Q1 2026, $15.0 million in Q4 2025, and $14.8 million in Q3 2025.